Blog
Keep up to date with the latest news from Instem.
Instem Interact 2026 – A Resounding Success
Turning Insight into Innovation in Preclinical R&D
d-wise Appoints 2x-CEO, ex-Labcorp Head of Software Solutions to Drive Next Phase of Strategy & Growth
BOSTON, USA – 21 April 2026: d-wise (an Instem company), a leader in statistical computing infrastructure and clinical trial transparency, today announced the appointment of Christine Oliver as its President. Christine brings over two decades...
Instem Taps ex-Novartis Head of Emerging Technologies to Put Science Behind Practical AI and NAMs
Instem, a leading provider of SaaS solutions for preclinical R&D, today announced the appointment of Szczepan Baran, VMD, MS, as Chief Scientific Officer. In the role, Szczepan will lead scientific and AI strategy across in...
Instem Announces Major UK Headquarters Refurbishment
Modernised Headquarters Underscores Instem’s Commitment to Innovation, Customer Excellence and the Local Region
Instem Relaunches the d-wise Brand to Support the Clinical Research Community
We are excited to announce the revival of the d-wise brand to represent Instem’s Clinical Trial Analytics and Transparency offerings. This movement returns our clinical portfolio to its roots while reinforcing our dedication to supporting...
Instem Unveils New Global Headquarters in Boston, MA
A Bold Step Reflecting Customer Obsession, Strategic Growth, and a New Era for Instem
Unifying Acquisitions Under One Instem Brand
A strategic evolution that will help you move faster, make more informed decisions, and deliver greater value through your research.
Instem achieves a major milestone, acquires all shares of Xybion from Banerjee Group LLC controlled by Dr. Pradip K. Banerjee
Instem has completed its acquisition of Xybion Digital, creator of the Pristima™ preclinical study management platform.
Instem Announces Acquisition of RockStep Solutions, Inc.
Instem Strengthens Preclinical Capabilities with RockStep Acquisition and Climb™ Integration
